1.25
0.03 (2.46%)
0.03 (2.46%)
Upgrade to Real-Time
Premarket
| Volume | 1,296 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.03 | 2.46% | 1.25 | 08:47:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.22 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 26 | 1,296 | - | 0.8361 - 4.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:47:52 | 20 | $ 1.25 | USD |
Period:
Draw Mode:
Zynerba Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 56.53M | 44.86M | 42.95M | $ - | $ - | -0.93 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 424.66k | 6.90% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.13 | 1.27 | 1.10 | 1.18 | 456,085 | 0.12 | 10.62% |
| 1 Month | 1.13 | 1.3193 | 1.05 | 1.18 | 417,612 | 0.12 | 10.62% |
| 3 Months | 0.91 | 1.60 | 0.855 | 1.18 | 558,916 | 0.34 | 37.36% |
| 6 Months | 2.72 | 2.94 | 0.8361 | 1.52 | 449,560 | -1.47 | -54.04% |
| 1 Year | 4.34 | 4.67 | 0.8361 | 3.36 | 970,365 | -3.09 | -71.2% |
| 3 Years | 11.66 | 12.51 | 0.8361 | 4.77 | 1,314,014 | -10.41 | -89.28% |
| 5 Years | 6.23 | 16.47 | 0.8361 | 6.21 | 1,143,748 | -4.98 | -79.94% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |